In person As in previous years, ZoBio is proud to be part of the 16th Swiss Course on Medicinal Chemistry in Leysin! This five-day Medicinal Chemistry School, organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society , focuses on the most cutting-edge aspects of small molecule drug discovery, highlighting methodologies…
Discovery on Target
In person ZoBio will participate in Discovery on Target, the industry’s premier event focused on novel drug targets and cutting-edge technologies for drug discovery professionals. The conference always showcase the latest advancements in both current and emerging “hot” targets, as well as innovative target validation strategies for developing novel therapeutic agents, from biologics to small…
10th RSC-BMCS Fragment-based Drug Discovery Meeting
In person ZoBio is pleased to attend the RSC-BMCS Fragment-Based Drug Discovery meeting in Cambridge this September. ZoBio will be represented by Johan Veerman | LinkedIn, Head of Chemistry, who will also present a poster entitled: Site-selective screening: Design, synthesis and application of stable S-adenosylmethionine-based probes for fragment screening against METTL3/14 We look forward to…
EFMC International Symposium on Medicinal Chemistry 2026
In person At the upcoming EFMC conference in Basel, Masakazu Kobayashi | LinkedIn, Head of Assay Development and Screening at ZoBio, will present the poster: Tailor-made Biophysics – A Versatile Toolkit for Discovery and Validation. The poster will showcase selected case studies demonstrating how flexible biophysical strategies can help address diverse discovery challenges from fragment-based…